Johnson & Johnson declined to comment on a report that the FDA threw away 60 million doses of its COVID-19 vaccine that was produced at a struggling Maryland facility over fears of possible contamination. The report, published by The New York Times, cited people familiar with the situation and comes as the FDA announced it was clearing two batches of the vaccine produced at the Emergent BioSolutions facility in Baltimore but found “several other batches.” not usable.
The FDA also noted in a press release issued Friday that “additional lots are still under review and the agency will keep the public informed as these reviews are completed.” At present, the agency said it was “not yet ready to include the Emergent BioSolutions plant in the Janssen EUA as an authorized manufacturing facility” and continues to ” resolve issues with Janssen and the management of Emerging BioSolutions ”.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
A spokesperson for Johnson & Johnson declined to comment on Fox News on the matter.
This is a developing story, please keep checking for updates.